Hennion & Walsh Asset Management Inc. lowered its position in CME Group Inc. (NASDAQ:CME - Free Report) by 22.9% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 8,456 shares of the financial services provider's stock after selling 2,518 shares during the quarter. Hennion & Walsh Asset Management Inc.'s holdings in CME Group were worth $2,243,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors have also modified their holdings of CME. Spire Wealth Management grew its stake in shares of CME Group by 37.4% in the 4th quarter. Spire Wealth Management now owns 1,320 shares of the financial services provider's stock valued at $307,000 after purchasing an additional 359 shares during the last quarter. Boston Trust Walden Corp grew its position in CME Group by 6.0% in the 4th quarter. Boston Trust Walden Corp now owns 16,569 shares of the financial services provider's stock valued at $3,848,000 after buying an additional 935 shares during the last quarter. Trust Point Inc. increased its stake in CME Group by 7.6% in the 4th quarter. Trust Point Inc. now owns 1,021 shares of the financial services provider's stock valued at $237,000 after buying an additional 72 shares during the period. Calamos Wealth Management LLC purchased a new position in CME Group during the 4th quarter worth $207,000. Finally, Brown Lisle Cummings Inc. lifted its stake in shares of CME Group by 252.0% in the 4th quarter. Brown Lisle Cummings Inc. now owns 352 shares of the financial services provider's stock worth $82,000 after acquiring an additional 252 shares during the period. 87.75% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling
In other CME Group news, Director Daniel G. Kaye sold 500 shares of the company's stock in a transaction dated Thursday, May 22nd. The shares were sold at an average price of $282.42, for a total value of $141,210.00. Following the completion of the transaction, the director now directly owns 3,668 shares of the company's stock, valued at $1,035,916.56. This represents a 12.00% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, General Counsel Jonathan L. Marcus sold 390 shares of CME Group stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $277.50, for a total value of $108,225.00. Following the sale, the general counsel now owns 6,708 shares in the company, valued at $1,861,470. This represents a 5.49% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 22,900 shares of company stock valued at $6,147,935. 0.30% of the stock is currently owned by corporate insiders.
CME Group Price Performance
CME traded down $2.98 during midday trading on Thursday, reaching $274.90. 1,957,832 shares of the company's stock were exchanged, compared to its average volume of 2,186,594. The business's 50-day moving average price is $271.26 and its 200 day moving average price is $252.28. The stock has a market capitalization of $99.06 billion, a PE ratio of 28.43, a P/E/G ratio of 6.76 and a beta of 0.45. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $290.79. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02.
CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.61 by $0.19. The business had revenue of $1.64 billion for the quarter, compared to the consensus estimate of $1.56 billion. CME Group had a return on equity of 13.62% and a net margin of 57.52%. The business's revenue was up 10.4% on a year-over-year basis. During the same period in the prior year, the business earned $2.50 earnings per share. As a group, equities analysts anticipate that CME Group Inc. will post 10.49 EPS for the current fiscal year.
CME Group Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Monday, June 9th will be issued a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.82%. The ex-dividend date is Monday, June 9th. CME Group's payout ratio is currently 50.30%.
Analysts Set New Price Targets
CME has been the topic of a number of recent analyst reports. Raymond James upgraded shares of CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 price target on the stock in a research note on Monday, March 10th. Piper Sandler boosted their target price on CME Group from $275.00 to $283.00 and gave the stock an "overweight" rating in a research report on Tuesday, April 8th. Bank of America raised their price target on CME Group from $200.00 to $219.00 and gave the company an "underperform" rating in a report on Wednesday, April 2nd. UBS Group upped their price objective on CME Group from $290.00 to $305.00 and gave the stock a "buy" rating in a report on Friday, April 25th. Finally, JPMorgan Chase & Co. reduced their target price on CME Group from $223.00 to $211.00 and set an "underweight" rating for the company in a report on Thursday, April 24th. Three equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and five have assigned a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $258.20.
Check Out Our Latest Research Report on CME Group
CME Group Company Profile
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Articles

Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.